Abbott Laboratories Financial Overview
Abbott Laboratories's market cap is currently $213.10B. The company's EPS TTM is $1.3; its P/E ratio is 15.37; and it has a dividend yield of 1.91%. Abbott Laboratories is scheduled to report earnings on October 15, 2025, and the estimated EPS forecast is $1.50. See an overview of income statement, balance sheet, and cash flow financials.
